WallachBeth Further Bolsters Quantitative Capabilities With Chief Technology Officer Hire

New York, New York, UNITED STATES

NEW YORK, Nov. 11, 2014 (GLOBE NEWSWIRE) -- WallachBeth Capital, a leading provider of institutional execution solutions for buy-side investment managers, announced that quantitative trading veteran Matthew Rowley has been appointed to the newly-created role of Chief Technology Officer. Mr. Rowley brings close to 20 years of experience to WallachBeth, most recently serving as Head of Alternative Execution at Crédit Agricole Cheuvreux, where he was credited with helping the firm attain a leadership position in the global electronic brokerage space.

According to David Beth, President and Chief Operating Officer of WallachBeth, "As our business model continues to evolve and expand, we are determined to stay at the forefront of the industry by providing our clients and our execution groups with the most advanced and innovative technology-based solutions."

Added Beth, "Our hiring Matt highlights our ongoing commitment to maintaining a collaborative approach whenever working with our clients; Matt is uniquely qualified to help us deliver customized solutions that address specific and often complex order execution and related business process needs."

Mr. Rowley's background includes senior executive roles for several of the financial industry's leading firms. Prior to joining Cheuvreux, he was Global Head of Advanced Trading Products at financial software vendor Fidessa. He began his career as a Quantitative Analyst in the Strategic Risk Management Advisory group at First Chicago Corp. Rowley holds an Advanced Degree in Applied Statistics from Oxford University and a First Class Honors degree in Mathematics.

About WallachBeth Capital

WallachBeth Capital is a leading provider of institutional execution services, offering its clients a full spectrum of solutions to help them navigate increasingly complex markets. The firm's expertise includes ETF and equity trading, derivatives, CEFs, fixed income and healthcare research. Operating on a fully disclosed, agency-only basis, the firm is committed to facilitating all client needs with transparency and integrity. The firm's website is located at www.wallachbeth.com.